What is ANI Pharmaceuticals's long-term debt?

ANI Pharmaceuticals (ANIP) reported long-term debt of $286M in Q1 2026.

How has ANI Pharmaceuticals's long-term debt changed year-over-year?

ANI Pharmaceuticals's long-term debt decreased by 6.3% year-over-year, from $305.29M to $286M.

What is the long-term trend for ANI Pharmaceuticals's long-term debt?

Over 5 years (2020 to 2025), ANI Pharmaceuticals's long-term debt has grown at a 11.1% compound annual growth rate (CAGR), from $172.44M to $291.84M.

What does long-term debt mean?

Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.

ANI Pharmaceuticals ANIP Long-Term Debt

Long-Term Debt at other companies

Amneal Pharmaceuticals, Inc.AMRX

$2.57B+19.1%

ViatrisVTRS

$12.41B-12.4%

AmgenAMGN

$51.89B-3.9%

Viridian Therapeutics, Inc.VRDN

$36.09M+74.5%

OrganonOGN

$8.55B-4.3%

Cardinal HealthCAH

——

Other financials

Income statement

See full

Revenue$237.5M+20.5%

Gross profit$143.9M+16.0%

Operating income$38.9M+48.5%

Net income$29.5M+88.1%

EPS (diluted)$1.28+85.5%

Balance sheet

See full

Cash & equivalents$311.2M+108%

Total debt$305.3M-3.5%

Total equity$562.3M+34.3%

Total assets$1.4B+10.0%

Cash flow

See full

Operating cash flow$58.4M+66.8%

CapEx$6.1M+146%

Free cash flow$52.3M+60.8%

Valuation

See full

Market cap$1.89B+18.3%

Enterprise value$1.88B+5.8%

P/E20.5×—

P/S2×-0.3×

Profitability

See full

Gross margin60.8%+1.5pp

Operating margin13.4%—

Net margin10%+8.1pp

FCF margin20.7%+10.8pp

Returns & leverage

See full

Return on equity18.8%+15.6pp

Debt / equity0.5×-0.2×

Current ratio3.1×+0.5×

Where this comes from

Reported directly by ANI Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.

The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANI Pharmaceuticals's long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ANI Pharmaceuticals's long-term debt?: ANI Pharmaceuticals (ANIP) reported long-term debt of $286M in Q1 2026.
How has ANI Pharmaceuticals's long-term debt changed year-over-year?: ANI Pharmaceuticals's long-term debt decreased by 6.3% year-over-year, from $305.29M to $286M.
What is the long-term trend for ANI Pharmaceuticals's long-term debt?: Over 5 years (2020 to 2025), ANI Pharmaceuticals's long-term debt has grown at a 11.1% compound annual growth rate (CAGR), from $172.44M to $291.84M.
What does long-term debt mean?: Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.